Lung cancer histology, stage, treatment, and survival in American Indians and Alaska Natives and whites

Cancer

Volumn 116, Issue 20, 2010, Pages 4810-4816

  Fesinmeyer, Megan Dann ^a   Goulart, Bernardo ^a   Blough, David K ^b   Buchwald, Dedra ^b   Ramsey, Scott D ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Health status disparities; Histology; Lung cancer; Operative therapy; Survival

Indexed keywords

ADULT; AGED; AMERICAN INDIAN; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CAUCASIAN; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HEALTH DISPARITY; HISTOPATHOLOGY; HUMAN; INDIGENOUS PEOPLE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING; SURVIVAL RATE; UNITED STATES; ETHNOLOGY; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; TIME;

AGED; AGED, 80 AND OVER; ALASKA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INDIANS, NORTH AMERICAN; LUNG NEOPLASMS; MIDDLE AGED; SEER PROGRAM; TIME FACTORS;

EID: 78349233868     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25410     Document Type: Article

References (29)

1. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93. (Pubitemid 38519418)
2. Wiggins CL, Espey DK, Wingo PA, et al. Cancer among American Indians and Alaska Natives in the United States, 1999-2004. Cancer. 2008;113(5 suppl):1142-1152.
3. Bliss A, Cobb N, Solomon T, et al. Lung cancer incidence among American Indians and Alaska Natives in the United States, 1999-2004. Cancer. 2008;113(5 suppl):1168-1178.
4. Sugarman JR, Dennis LK, White E. Cancer survival among American Indians in western Washington State (United States). Cancer Causes Control. 1994;5:440-448. (Pubitemid 24302708)
5. Wang SJ, Fuller CD, Thomas CR Jr. Ethnic disparities in conditional survival of patients with non-small cell lung cancer. J Thorac Oncol. 2007;2:180-190. (Pubitemid 47181322)
6. Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol. 2007;25:5570-5577.
7. Horner MR, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; Year [serial online]. Available at: http://seer.-cancer.gov/csr/1975-2006/. Accessed March 22, 2010.
8. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program Website [serial online]. Available at: http://www.seer.cancer. gov. Accessed March 22, 2010.
9. Fritz A, Percy C, Jack A, et al. (eds). International Classification of Diseases for Oncology, 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
10. Zell JA, Ou SH, Ziogas A, et al. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol. 2005;23:8396-8405.
11. Franklin WA, Chanin T, Gonzalez A. Molecular and cellular pathology of lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD, Carbone DP, eds. Lung Cancer: Principles and Practices. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2005:235-238.
12. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease. Nat Rev Cancer. 2007;7:778-790. (Pubitemid 47463669)
13. Eichner JE, Cravatt K, Beebe LA, et al. Tobacco use among American Indians in Oklahoma: an epidemiologic view. Public Health Rep. 2005;120:192-199.
14. Davis WW, Hartman AM, Gibson JT. Trends in Smoking Prevalence by Race based on the Tobacco Use Supplement to the Current Population Survey. Bethesda, MD: National Cancer Institute [monograph online]. Available at: http://www.fcsm.gov/07papers/Davis. VII-C.pdf. Accessed March 22, 2010.
15. Dennis TD. Cancer stage at diagnosis, treatment, and survival among American Indians and non-American Indians in Montana. Cancer. 2000;89:181-186. (Pubitemid 30451289)
16. Daniels LJ, Balderson SS, Onaitis MW, et al. Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. Ann Thorac Surg. 2002;74:860-864. (Pubitemid 35001818)
17. Kirby TJ, Mack MJ, Landreneau RJ, et al. Lobectomy-video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. J Thorac Cardiovasc Surg. 1995;109:997-1001; discussion 1001-1002.
18. Demmy TL, Curtis JJ. Minimally invasive lobectomy directed toward frail and high-risk patients: a case-control study. Ann Thorac Surg. 1999;68:194-200. (Pubitemid 29338989)
19. Chhatwani L, Cabebe E, Wakelee HA. Adjuvant treatment of resected lung cancer. Proc Am Thorac Soc. 2009;6:194-200.
20. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;350:351-360. (Pubitemid 38101630)
21. Pepe C, Hasan B, Winton TL, et al. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol. 2007;25:1553-1561. (Pubitemid 46733082)
22. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006;7:719-727. (Pubitemid 44283661)
23. Lang K, Marciniak MD, Faries D, et al. Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States. Lung Cancer. 2009;63:264-270.
24. Morgensztern D, Goodgame B, Baggstrom MQ, et al. The effect of FDG-PET on the stage distribution of non-small cell lung cancer. J Thorac Oncol. 2008;3:135-139. (Pubitemid 351323187)
25. Parsons A, Daley A, Begh R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with metaanalysis. BMJ. 2010;340:b5569.
26. Janjigian YY, McDonnell K, Kris MG, et al. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer. 2009;116:670-675.
27. Movsas B, Moughan J, Sarna L, et al. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol. 2009;27:5816-5822.
28. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117-2127. (Pubitemid 37464537)
29. Bach PB, Cramer LD, Schrag D, et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001;345:181-188. (Pubitemid 32662128)